Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/02/2003WO2003080736A1 Use of oxazine dyes as marking groups for single molecule analysis
10/02/2003WO2003080676A1 Antibody against transferrin-containing immune complex, process for producing the antibody, hybridoma and immunoassay method
10/02/2003WO2003080661A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
10/02/2003WO2003080658A1 Novel allergen
10/02/2003WO2003080649A2 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080587A1 Labelled taxanes
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003080327A1 Multiple-property composite beads and preparation and use thereof
10/02/2003WO2003080209A2 Method of concentrating macromolecules or agglomerates of molecules or particles
10/02/2003WO2003080120A1 Test system for evaluating the compatibility of biologically active substances with copolymers
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080100A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63)
10/02/2003WO2003080099A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
10/02/2003WO2003080098A2 Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
10/02/2003WO2003080097A2 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079982A2 Gene amplification in cancer
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079974A2 Integrin ligand
10/02/2003WO2003079921A1 Diagnosis marker
10/02/2003WO2003079906A1 Method and apparatus for analyzing mammary gland fluid
10/02/2003WO2003079900A1 Noninvasive blood component value measuring instrument and method
10/02/2003WO2003079884A2 Methods for diagnosis and prognosis of cancer
10/02/2003WO2003079826A2 Method for the controlled fermentation of drinks by means of sensors and automated analytical methods
10/02/2003WO2003079748A2 Potentiation of cancer therapies by znf217 inhibition
10/02/2003WO2003065032A3 System and method for preventing fouling in sensors
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003060479A3 Sample testing device
10/02/2003WO2003056318A3 Method for the determination of nitrogen oxides in an exhaust gas and device for exhaust gas treatment
10/02/2003WO2003052407A8 Analytical method and apparatus for analysis for surfactants in hydrocarbon distillate fuels
10/02/2003WO2003050530A3 Use of microwaves in the spinning industry for measuring sliver mass
10/02/2003WO2003050503A3 Multiple binding moiety chromatography device, methods of using and methods of making same
10/02/2003WO2003048753A3 A method and device for measuring atomic hydrogen flow density
10/02/2003WO2003047037A9 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003042701A3 Method for diagnosing multiple sclerosis and an assay therefore
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003034803A3 Methods for determining toxicity reversing agents
10/02/2003WO2003023363A3 Microcantilever apparatus and methods for detection of enzymes
10/02/2003WO2003015692A3 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003006627A3 Leukemogenic transcription factors
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2002101390A3 Method for detecting rheumatoid arthritis-specific autoantibodies
10/02/2003WO2002101015A3 Integrative assays for monitoring molecular assembly events
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002081691A9 Abcg5 and abcg8: compositions and methods of use
10/02/2003WO2002073176A3 Sensor for detecting gas
10/02/2003WO2002070737A9 Compositions and methods relating to osteoarthritis
10/02/2003WO2002064794A3 Herbicide target genes and methods
10/02/2003WO2002063037A3 Method for identifying functional nucleic acids
10/02/2003WO2002059355A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/02/2003WO2002048139A3 Oxazolidinone photoaffinity probes
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002040996A9 Differential gene expression in specific regions of the brain in neurodegenerative diseases
10/02/2003WO2002036818A3 Method for detecting inhibitors of tumour growth
10/02/2003WO2002035205A9 Process for detecting or quantifying a biological reaction using superparamagnetic label
10/02/2003WO2002033596A3 Method of operating a computer system to perform a discrete substructural analysis
10/02/2003WO2002031463A3 High density column and row addressable electrode arrays
10/02/2003WO2002029104A3 Tumor marker and methods of use
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002004948A3 Distinguishing molecular forms
10/02/2003WO2002004677A3 Methods for diagnosis and treatment of psychiatric disorders
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003WO2001083814A3 Assay for nucleic acid analysis
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030188326 Detecting cell proliferative disorders associated with breast, ovaries or prostate via monitoring mutation in gene associated with franconi anemia; antitumor/antiproliferative agents
10/02/2003US20030188325 Genetically engineered rodent cells comprising mutated regulatory erythroid kinase (REDK) gene for treatment of blood disorders such as anemia; animal models
10/02/2003US20030188279 Clustering for data compression
10/02/2003US20030187606 Method and apparatus for a combustionless BTU measurement meter
10/02/2003US20030187593 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
10/02/2003US20030187590 Humoral testing unit
10/02/2003US20030187589 Humoral testing unit and a humoral testing apparatus
10/02/2003US20030187588 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187227 Solid phase synthesis
10/02/2003US20030187220 Generating computer readable database comprising three-dimensional molecular structural cooridinates of flavin oxidureductase polypeptide; enzyme inhibitors; microbiocides
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
1 ... 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 ... 3937